Andrea B. Thomas - Feb 7, 2023 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Stock symbol
MED
Transactions as of
Feb 7, 2023
Transactions value $
$1,110
Form type
4
Date filed
2/9/2023, 08:04 PM
Previous filing
Nov 10, 2022
Next filing
May 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Purchase $1.11K +9.66 +0.32% $114.97 3.03K Feb 7, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.